Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001887859 | SCV002125596 | uncertain significance | not provided | 2023-09-05 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt GATAD2B protein function. ClinVar contains an entry for this variant (Variation ID: 1354705). This missense change has been observed in individual(s) with clinical features of GATAD2B-related conditions (Invitae). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 251 of the GATAD2B protein (p.Ala251Thr). |
Ambry Genetics | RCV003264129 | SCV003972890 | uncertain significance | Inborn genetic diseases | 2023-04-07 | criteria provided, single submitter | clinical testing | The c.751G>A (p.A251T) alteration is located in exon 6 (coding exon 5) of the GATAD2B gene. This alteration results from a G to A substitution at nucleotide position 751, causing the alanine (A) at amino acid position 251 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Genome- |
RCV003339765 | SCV004050303 | uncertain significance | Severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome | 2023-04-11 | criteria provided, single submitter | clinical testing |